Cloud infrastructures for in silico drug discovery: economic and practical aspects.
Cloud computing opens new perspectives for small-medium biotechnology laboratories that need to perform bioinformatics analysis in a flexible and effective way. This seems particularly true for hybrid clouds that couple the scalability offered by generalpurpose public clouds with the greater control...
| Published in: | BioMed Research International Vol. 2013; pp. 138012 - 138013 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Published: |
Wiley-Blackwell
2013
|
| Online Access: | View this record in EBSCOhost |